Clinical Trials on Gastrointestinal Neuroendocrine Tumor
Total 38730 results
-
M.D. Anderson Cancer CenterTerSera Therapeutics LLCRecruitingLocally Advanced Neuroendocrine Neoplasm | Metastatic Neuroendocrine NeoplasmUnited States
-
Alberta Health servicesRecruiting
-
AHS Cancer Control AlbertaCross Cancer InstituteActive, not recruiting
-
Advanced Accelerator ApplicationsActive, not recruitingNeuroendocrine TumorsUnited Kingdom, Portugal, Spain, France, United States
-
Jules Bordet InstituteCompletedGastroenteropancreatic Neuroendocrine TumorsBelgium
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedNeuroendocrine Tumors | Pancreatic Neuroendocrine TumorsCanada
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCCompletedNeuroendocrine Tumors | Metastatic Neuroendocrine TumorsUnited States
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Gruppo Oncologico del Nord-OvestRecruitingMerkel Cell CarcinomaItaly
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLC; Novartis; GI Research FoundationRecruitingMerkel Cell CarcinomaUnited States
-
Abramson Cancer Center at Penn MedicineMerck Sharp & Dohme LLCRecruitingMerkel Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
University of BirminghamEfficacy and Mechanism Evaluation (EME) ProgrammeCompletedMerkel Cell CarcinomaUnited Kingdom
-
Merck Sharp & Dohme LLCCompletedMerkel Cell CarcinomaUnited States, Australia, Canada, France, Italy, New Zealand, Spain, Sweden
-
Immunomic Therapeutics, Inc.Completed
-
ImmunityBio, Inc.TerminatedMerkel Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedGastro-enteropancreatic Neuroendocrine Tumor | Secondary Malignant Neoplasm of LiverUnited States
-
4SC AGMerck KGaA, Darmstadt, GermanyWithdrawn
-
ImmunityBio, Inc.Withdrawn
-
Immune DesignCompletedMerkel Cell CarcinomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)RecruitingCarcinoid Syndrome | Metastatic Nonfunctional Well Differentiated Neuroendocrine NeoplasmUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedGastric Cancer | Colorectal Cancer | Small Intestine Cancer | Ovarian Cancer | Peritoneal Cavity Cancer | Gastrointestinal Stromal Tumor | Gastrointestinal Carcinoid TumorUnited States
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
National Cancer Institute (NCI)CompletedRecurrent Neuroendocrine Carcinoma of the Skin | Stage III Neuroendocrine Carcinoma of the Skin | Stage IV Neuroendocrine Carcinoma of the Skin | Stage II Neuroendocrine Carcinoma of the Skin | Stage I Neuroendocrine Carcinoma of the SkinUnited States
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Chang Gung Memorial Hospital; Kaohsiung... and other collaboratorsCompletedNeuroendocrine CarcinomasTaiwan
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Gastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Stage... and other conditionsUnited States
-
Teclison Ltd.Active, not recruitingHepatocellular Carcinoma | Neuroendocrine Tumors | Gastrointestinal Cancer MetastaticUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Extrapulmonary Neuroendocrine Carcinoma | Metastatic Extrapulmonary Neuroendocrine Carcinoma | Recurrent Extrapulmonary Neuroendocrine Carcinoma | Unresectable Extrapulmonary Neuroendocrine CarcinomaUnited States
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbHRecruiting
-
University Hospital, ToursEuropean Academy of Dermatology and VenerologyNot yet recruitingMerkel Cell CarcinomaUnited Kingdom, Austria, Finland, France, Germany, Italy, Netherlands, Romania, Sweden, Turkey
-
Prof. Dr. med. Dirk SchadendorfBristol-Myers SquibbActive, not recruitingMerkel Cell CarcinomaGermany, Netherlands
-
OncoSec Medical IncorporatedNational Cancer Institute (NCI)CompletedMerkel Cell CarcinomaUnited States
-
Stanford UniversityTerminatedMerkel Cell CarcinomaUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.Completed
-
Philogen S.p.A.Immatics Biotechnologies GmbHTerminatedMerkel Cell CarcinomaGermany, Austria, Denmark, France, Spain, United Kingdom
-
Rambam Health Care CampusCompleted
-
Peking UniversityNot yet recruiting
-
University Hospital, ToulouseActive, not recruitingMidgut Neuroendocrine TumorsFrance
-
Istituto Scientifico Romagnolo per lo Studio e...Active, not recruiting
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsGermany, Austria
-
Uppsala UniversityUnknown
-
IpsenTerminatedNeuroendocrine Tumors in LungCanada, United States, Germany, France, United Kingdom, Netherlands, Spain, Denmark, Italy, Austria, Poland
-
Grupo Espanol de Tumores NeuroendocrinosCompleted
-
Jules Bordet InstituteWithdrawnGastro-intestinal Neuroendocrine TumorsBelgium
-
Fujian Medical UniversityCompletedGastric Neuroendocrine CarcinomaChina
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Not yet recruiting
-
Power Life Sciences Inc.Not yet recruitingMerkel Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterEMD SeronoRecruitingMerkel Cell CarcinomaUnited States
-
Kartos Therapeutics, Inc.RecruitingMerkel Cell CarcinomaUnited States, Netherlands, Korea, Republic of, France, Germany, Spain, Canada, Italy, Australia, Brazil